There has been renewed interest in the laboratory diagnosis of Clostridium difficile infections due ... B have been the most widely used diagnostic test for diagnosis of C. difficile infections.
The C. diff study was funded in part by BioNTech, which made some of the mRNA COVID-19 vaccines with Pfizer.In addition, Penn ...
The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...
Clostridioides difficile (previously known as Clostridium difficile) is a highly contagious organism that primarily impacts ...
Once C-diff is in the ascendancy it can be very hard ... only 6% of potential donors make it through the rigorous testing programme. Although this treatment is relatively new it has had staggering ...